These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Epidemiology of Human Papilloma Virus (HPV) in Cervical Mucosa. Chauhan SC; Jaggi M; Bell MC; Verma M; Kumar D Methods Mol Biol; 2009; 471():439-56. PubMed ID: 19109793 [TBL] [Abstract][Full Text] [Related]
25. Recombinant vaccines for the prevention of human papillomavirus infection and cervical cancer. Palmer KE; Jenson AB; Kouokam JC; Lasnik AB; Ghim SJ Exp Mol Pathol; 2009 Jun; 86(3):224-33. PubMed ID: 19454268 [TBL] [Abstract][Full Text] [Related]
26. Human papillomaviruses and genital disease. Ahmed AM; Madkan V; Tyring SK Dermatol Clin; 2006 Apr; 24(2):157-65, vi. PubMed ID: 16677964 [TBL] [Abstract][Full Text] [Related]
27. Cutaneous human papillomavirus infection: manifestations and diagnosis. Tschandl P; Rosendahl C; Kittler H Curr Probl Dermatol; 2014; 45():92-7. PubMed ID: 24643180 [TBL] [Abstract][Full Text] [Related]
28. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. Bernard HU J Clin Virol; 2005 Mar; 32 Suppl 1():S1-6. PubMed ID: 15753006 [TBL] [Abstract][Full Text] [Related]
29. [Human papilloma virus (HPV) infections of the skin and mucous membranes. Epidemiology, physiopathology, diagnosis, treatment]. Ann Dermatol Venereol; 2000 Oct; 127(Spec No 1):A192-7. PubMed ID: 11474523 [No Abstract] [Full Text] [Related]
30. Betapapillomaviruses: innocent bystanders or causes of skin cancer. Feltkamp MC; de Koning MN; Bavinck JN; Ter Schegget J J Clin Virol; 2008 Dec; 43(4):353-60. PubMed ID: 18986829 [TBL] [Abstract][Full Text] [Related]
31. Searching for antiviral drugs for human papillomaviruses. Underwood MR; Shewchuk LM; Hassell AM; Phelps WC Antivir Ther; 2000 Dec; 5(4):229-42. PubMed ID: 11142617 [TBL] [Abstract][Full Text] [Related]
32. Therapy of cutaneous human Papillomavirus infections. Rivera A; Tyring SK Dermatol Ther; 2004; 17(6):441-8. PubMed ID: 15571494 [TBL] [Abstract][Full Text] [Related]
34. Human papilloma virus and oral infections: an update. Kumaraswamy KL; Vidhya M J Cancer Res Ther; 2011; 7(2):120-7. PubMed ID: 21768696 [TBL] [Abstract][Full Text] [Related]
35. Presumed previous human papillomavirus (HPV) related gynecological cancer in women diagnosed with anal cancer in the province of Ontario. Jiménez W; Paszat L; Kupets R; Wilton A; Tinmouth J Gynecol Oncol; 2009 Sep; 114(3):395-8. PubMed ID: 19501390 [TBL] [Abstract][Full Text] [Related]
36. Integrating human papillomavirus vaccination in cervical cancer control programmes. Franco EL; Coutlée F; Ferenczy A Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447 [TBL] [Abstract][Full Text] [Related]
37. Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions. Coutlée F; Trottier H; Gagnon S; Koushik A; Richardson H; Roger M; Ferenczy AS; Franco EL J Clin Virol; 2009 Jun; 45(2):96-9. PubMed ID: 19398216 [TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus and immunosuppression. Wieland U; Kreuter A; Pfister H Curr Probl Dermatol; 2014; 45():154-65. PubMed ID: 24643184 [TBL] [Abstract][Full Text] [Related]
39. The spectrum and clinical sequelae of human papillomavirus infection. Monk BJ; Tewari KS Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S6-13. PubMed ID: 18499914 [TBL] [Abstract][Full Text] [Related]
40. Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin. Waterboer T; Abeni D; Sampogna F; Rother A; Masini C; Sehr P; Michael KM; Pawlita M Br J Dermatol; 2008 Aug; 159(2):457-9. PubMed ID: 18503604 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]